part i item 1 . business . merck & co. , inc . ( 201cmerck 201d or the 201ccompany 201d ) is a global health care company that delivers innovative health solutions through its prescription medicines , vaccines , biologic therapies , animal health , and consumer care products , which it markets directly and through its joint ventures . the company 2019s operations are principally managed on a products basis and are comprised of four operating segments , which are the pharmaceutical , animal health , consumer care and alliances segments , and one reportable segment , which is the pharmaceutical segment . the pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures . human health pharmaceutical products consist of therapeutic and preventive agents , generally sold by prescription , for the treatment of human disorders . the company sells these human health pharmaceutical products primarily to drug wholesalers and retailers , hospitals , government agencies and managed health care providers such as health maintenance organizations , pharmacy benefit managers and other institutions . vaccine products consist of preventive pediatric , adolescent and adult vaccines , primarily administered at physician offices . the company sells these human health vaccines primarily to physicians , wholesalers , physician distributors and government entities . the company also has animal health operations that discover , develop , manufacture and market animal health products , including vaccines , which the company sells to veterinarians , distributors and animal producers . additionally , the company has consumer care operations that develop , manufacture and market over-the- counter , foot care and sun care products , which are sold through wholesale and retail drug , food chain and mass merchandiser outlets , as well as club stores and specialty channels . the company was incorporated in new jersey in for financial information and other information about the company 2019s segments , see item 7 . 201cmanagement 2019s discussion and analysis of financial condition and results of operations 201d and item 8 . 201cfinancial statements and supplementary data 201d below . all product or service marks appearing in type form different from that of the surrounding text are trademarks or service marks owned , licensed to , promoted or distributed by merck , its subsidiaries or affiliates , except as noted . all other trademarks or services marks are those of their respective owners . product sales sales of the company 2019s top pharmaceutical products , as well as total sales of animal health and consumer care products , were as follows: .
|( $ in millions )|2013|2012|2011|
|total sales|$ 44033|$ 47267|$ 48047|
|pharmaceutical|37437|40601|41289|
|januvia|4004|4086|3324|
|zetia|2658|2567|2428|
|remicade|2271|2076|2667|
|gardasil|1831|1631|1209|
|janumet|1829|1659|1363|
|isentress|1643|1515|1359|
|vytorin|1643|1747|1882|
|nasonex|1335|1268|1286|
|proquad/m-m-rii/varivax|1306|1273|1202|
|singulair|1196|3853|5479|
|animal health|3362|3399|3253|
|consumer care|1894|1952|1840|
|other revenues ( 1 )|1340|1315|1665|
other revenues ( 1 ) 1340 1315 1665 ( 1 ) other revenues are primarily comprised of alliance revenue , miscellaneous corporate revenues and third-party manufacturing sales . on october 1 , 2013 , the company divested a substantial portion of its third-party manufacturing sales . table of contents .

Question: what is the growth rate in total sales in 2012?
Answer: -0.01623